ClinicalTrials.gov
ClinicalTrials.gov Menu

Developing Violence Prevention Therapy for Substance Abusers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00551863
Recruitment Status : Completed
First Posted : October 31, 2007
Last Update Posted : August 7, 2015
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Stephen Chermack, University of Michigan

Brief Summary:
The purpose of this project is to develop and pilot test a violence prevention intervention for men and women in treatment for substance use problems.

Condition or disease Intervention/treatment Phase
Substance Use Disorders Violence Behavioral: IVPT Phase 1 Phase 2

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 131 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Development of Violence Therapy for Substance Abusers
Study Start Date : June 2004
Actual Primary Completion Date : March 2008
Actual Study Completion Date : March 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Drug Abuse
U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: IVPT
Intervention based on Motivational Interviewing and CBT
Behavioral: IVPT
Violence prevention intervention based on Motivational Interviewing and CBT



Primary Outcome Measures :
  1. Interpersonal Violence [ Time Frame: 3 and 6 month follow-up ]

Secondary Outcome Measures :
  1. alcohol and drug use [ Time Frame: 3 and 6 month follow-up ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Presence of substance use related problems
  • Interpersonal Violence history in the year before recruitment

Exclusion Criteria:

  • Primary opiate dependence
  • Presence of active psychotic disorder
  • < 18 years of age

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00551863


Locations
United States, Michigan
University of Michigan
Ann Arbor, Michigan, United States, 48105
Sponsors and Collaborators
University of Michigan
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Stephen T Chermack, Ph.D. University of Michigan

Publications of Results:
Other Publications:

Responsible Party: Stephen Chermack, Principal Investigator, University of Michigan
ClinicalTrials.gov Identifier: NCT00551863     History of Changes
Other Study ID Numbers: R01DA017295-01A1 ( U.S. NIH Grant/Contract )
R01DA017295 ( U.S. NIH Grant/Contract )
First Posted: October 31, 2007    Key Record Dates
Last Update Posted: August 7, 2015
Last Verified: August 2015

Keywords provided by Stephen Chermack, University of Michigan:
alcohol, drugs, aggression, substance use disorder treatment

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders